USANA HEALTH SCIENCES, INC. Line of Credit, Current
USANA HEALTH SCIENCES, INC. (USNA) had Line of Credit, Current of $0 as of 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LinesOfCreditCurrent · last filed 2026-08-13
- 2026-07-04: Line of Credit, Current $0.00.
- 2026-04-04: Line of Credit, Current $14.00M.
- 2026-01-03: Line of Credit, Current $14.00M.
- 2025-09-27: Line of Credit, Current $0.00.
| Period end | Line of Credit, Current |
|---|---|
| 2026-07-04 | $0.00 10-Q · filed 2026-08-13 |
| 2026-04-04 | $14.00M 10-Q · filed 2026-05-12 |
| 2026-01-03 | $14.00M 10-Q · filed 2026-08-13 |
| 2025-09-27 | $0.00 10-Q · filed 2025-11-05 |
| 2025-06-28 | $0.00 10-Q · filed 2025-08-05 |
| 2025-03-29 | $23.00M 10-Q · filed 2025-05-06 |
| 2024-12-28 | $23.00M 10-K · filed 2026-03-16 |
| 2024-09-28 | $0.00 10-Q · filed 2024-11-05 |
| 2024-06-29 | $0.00 10-Q · filed 2024-08-06 |
| 2024-03-30 | $1.32M 10-Q · filed 2024-05-07 |
| 2023-12-30 | $786.00K 10-Q · filed 2024-11-05 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-27 |
| 2022-04-02 | $10.00M 10-Q · filed 2022-05-11 |
| 2022-01-01 | $0.00 10-Q · filed 2022-05-11 |
| 2016-10-01 | $1.20M 10-Q · filed 2016-11-09 |
| 2014-09-27 | $10.00M 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |